SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001628280-17-003789
Filing Date
2017-04-18
Accepted
2017-04-18 17:00:03
Documents
1
Period of Report
2017-04-18
Effectiveness Date
2017-04-18

Document Format Files

Seq Description Document Type Size
1 DEF 14A PROXY MAY 2017 proxymay2017.htm DEF 14A 939911
  Complete submission text file 0001628280-17-003789.txt   941111
Mailing Address 100-8900 GLENLYON PARKWAY BURNABY A1 V5J 5J8
Business Address 100-8900 GLENLYON PARKWAY BURNABY A1 V5J 5J8 604-419-3200
Arbutus Biopharma Corp (Filer) CIK: 0001447028 (see all company filings)

IRS No.: 980597776 | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-34949 | Film No.: 17767493
SIC: 2834 Pharmaceutical Preparations